Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06359080 · ClinicalTrials.gov registry record · NA

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

A NA study of Autism Spectrum Disorder, sponsored by JelikaLite.

Completed
Registry status
NA
Development phase
25
Enrollment target
2
Study locations

NCT06359080 is a NA study of Autism Spectrum Disorder that has completed, run by JelikaLite. The registered enrollment target is 25 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06359080, a NA study of Autism Spectrum Disorder, has completed, sponsored by JelikaLite.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

The hypothesis of the study is that photobiomodulation reduces symptoms of autism. Participants will be children between the ages of 2 and 7, who have been diagnosed with moderate to severe autism. Transcranial photobiomodulation will be administered to the children in the experimental condition twice a week for 10 weeks. Results will be measured through parental interviews, standardized CARS2 (Childhood Autism Rating Scales, 2nd Edition) and data collected from EEG.

Conditions Studied

Autism Spectrum Disorder

Interventions

  • DEVICE Cognilum TM: Light Treatment Condition

Study Locations (2)

New York

  • Dr. Steingold Psychology PC - Brooklyn
  • Dr. Steingold Psychology PC - New York

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-05-08
Est. Completion 2022-12-11
Phase NA

Sponsor

JelikaLite

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06359080

The ClinicalTrials.gov registry entry for NCT06359080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (81% lower). The listed sponsor is JelikaLite, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Cognilum TM: Light Treatment Condition is the first listed.

NCT06359080 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06359080 about?

NCT06359080 is a clinical study titled "Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)". The hypothesis of the study is that photobiomodulation reduces symptoms of autism. Participants will be children between the ages of 2 and 7, who have been diagnosed with moderate to severe autism. Transcranial photobiomodulation will be administered to the children in the experimental condition twi...

What is the current status of trial NCT06359080?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-05-08. Estimated completion is 2022-12-11.

What conditions does trial NCT06359080 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT06359080?

The interventions under investigation include: Cognilum TM: Light Treatment Condition (DEVICE).

Who is sponsoring clinical trial NCT06359080?

This trial is sponsored by JelikaLite, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06359080 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.